71 related articles for article (PubMed ID: 18346639)
1. Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis.
Zhang DL; Li JS; Jiang ZW; Yu BJ; Tang XM; Zheng HM
World J Gastroenterol; 2003 Apr; 9(4):824-8. PubMed ID: 12679941
[TBL] [Abstract][Full Text] [Related]
2. Effect of renal function under left ventricular assist device support on the cardiac function and clinical events after heart transplantation.
Kakuda N; Amiya E; Hatano M; Ishida J; Tsuji M; Bujo C; Yagi H; Fujita K; Ishii S; Isotani Y; Kurihara T; Numata G; Gyoten T; Shimada S; Ando M; Ono M; Komuro I
Clin Transplant; 2023 Dec; 37(12):e15107. PubMed ID: 37615650
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device.
Galeone A; Buccoliero C; Barile B; Nicchia GP; Onorati F; Luciani GB; Brunetti G
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203459
[TBL] [Abstract][Full Text] [Related]
4. Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension.
Engel Sällberg A; Helleberg S; Ahmed S; Ahmed A; Rådegran G
ESC Heart Fail; 2023 Dec; 10(6):3582-3591. PubMed ID: 37772417
[TBL] [Abstract][Full Text] [Related]
5. Reverse Remodeling With Left Ventricular Assist Devices.
Burkhoff D; Topkara VK; Sayer G; Uriel N
Circ Res; 2021 May; 128(10):1594-1612. PubMed ID: 33983828
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support.
Apostoli A; Bianchi V; Bono N; Dimasi A; Ammann KR; Moiia YR; Montisci A; Sheriff J; Bluestein D; Fiore GB; Pappalardo F; Candiani G; Redaelli A; Slepian MJ; Consolo F
J Heart Lung Transplant; 2019 Jun; 38(6):658-667. PubMed ID: 30846234
[TBL] [Abstract][Full Text] [Related]
7. Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case-control studies.
Zhang Y; Cao Y; Xin L; Gao N; Liu B
Medicine (Baltimore); 2018 Dec; 97(50):e13386. PubMed ID: 30557992
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor-Alpha and Interleukin-6 Gene Polymorphisms in Iranian Patients with Ischemic Heart Failure.
Hedayat M; Mahmoudi MJ; Taghvaei M; Nematipour E; Farhadi E; Esfahanian N; Mahmoudi M; Sadr M; Nourijelyani K; Amirzargar AA; Rezaei N
Avicenna J Med Biotechnol; 2018; 10(2):105-109. PubMed ID: 29849987
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.
Tabit CE; Coplan MJ; Chen P; Jeevanandam V; Uriel N; Liao JK
J Heart Lung Transplant; 2018 Jan; 37(1):107-115. PubMed ID: 28651907
[TBL] [Abstract][Full Text] [Related]
10. Device therapy and cardiac transplantation for end-stage heart failure.
Boilson BA; Raichlin E; Park SJ; Kushwaha SS
Curr Probl Cardiol; 2010 Jan; 35(1):8-64. PubMed ID: 19962044
[TBL] [Abstract][Full Text] [Related]
11. Cardiac recovery during mechanical assist device support.
Maybaum S; Kamalakannan G; Murthy S
Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
[TBL] [Abstract][Full Text] [Related]
12. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
